Search for: "ACTAVIS, INC."
Results 261 - 280
of 382
Sort by Relevance
|
Sort by Date
11 Aug 2011, 1:09 pm
Actavis Totowa, LLC, 2010 WL [read post]
5 Aug 2011, 12:29 pm
Manufacturers who have filed the appeal are: Actavis, Inc., Mylan, Inc., Teva Pharmaceutical Industries, and UDL Laboratories, Inc. [read post]
3 Aug 2011, 3:31 am
Patent and Trademark Office (Orange Book Blog) (IP Watch) (KEI) (Patent Docs) (Patent Docs) (IP Spotlight) (Patently-O) (Inventive Step) (Patentology) (Patent Law Practice Center) (IPBiz) (Out-Law) (PharmaPatents) (Maier & Maier) (Patent Docs) (Patent Baristas) Memantine – EU: CJEU ruling rejects pre-65/65 authorisations: Case C-195/09 Synthon v Merz Pharma (The SPC Blog) (EPLAW) Modafinil – UK: EWHC: Constructing a case for infringing particle-size patents: Cephalon Inc,… [read post]
1 Aug 2011, 8:19 am
The seven defendants, Actavis Elizabeth LLC, Sun Pharmaceuticals, Sandoz Inc., Mylan Pharmaceuticals, Apotex Inc., Aurobindo Pharma Ltd., and Teva Pharmaceuticals, had filed an Abbreviated New Drug Application (ANDA) seeking to utilize Lilly's patented formula and claiming invalidity of Lilly's patent, No. 5,658,590, Treatment of attention-deficit/hyperactivity disorder, which has been issued by the US Patent Office. [read post]
27 Jul 2011, 1:01 am
Paddock Laboratories, Inc. [read post]
29 Jun 2011, 3:34 am
Mensing; Actavis, Inc. v. [read post]
23 Jun 2011, 1:00 pm
The defendants included Actavis Inc. and other drug makers. [read post]
23 Jun 2011, 9:23 am
09-1039), and Actavis, Inc. v. [read post]
15 Jun 2011, 4:56 am
Actavis (Kluwer Patent Blog) Viagra (Sildenafil) – US: Patent infringement complaint filed in response to Para IV certification: Pfizer Inc. et al. v. [read post]
5 Jun 2011, 1:12 pm
Mensing Reverse Details Actavis v. [read post]
4 May 2011, 7:52 am
Brand Name Opioid Products Generic Name Trade Name Applicant/Sponsors Fentanyl Duragesic Extended Release Transdermal System Ortho McNeil Janssen Hydromorphone *Palladone Extended Release Capsules Purdue Pharma Methadone Dolophine Tablets Roxanne Morphine Avinza® Extended Release Capsules King Pharms Morphine Kadian® Extended Release Capsules Actavis Morphine MS Contin Extended Release Tablets Purdue Pharma… [read post]
21 Apr 2011, 11:14 pm
Pliva Inc. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
30 Mar 2011, 5:32 pm
Supreme Court in PLIVA Inc. v. [read post]
28 Mar 2011, 5:15 am
MENSING, GLADYS 09-1501 ACTAVIS, INC. v. [read post]
26 Mar 2011, 10:00 pm
Mensing (09-1039), and Talk America, Inc. v. [read post]
25 Mar 2011, 11:17 am
On March 30, in PLIVA, Inc. v. [read post]
22 Mar 2011, 4:21 pm
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly… well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
24 Feb 2011, 1:49 pm
Actavis Totowa, LLC, 2010 WL 3604674, at *3-4 (S.D. [read post]
